NCT01065454TerminatedPhase 2
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-center Study to Evaluate the Hemodynamic Effects of Riociguat (BAY 63-2521) as Well as Safety and Kinetics in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction
- Status (registry)
- Terminated
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 202 (actual)
- First submitted
- 8 Feb 2010
- Start date
- 14 Apr 2010
- Primary completion date
- 6 Jun 2012
- Lead sponsor
- Bayer
- Diseases
- Pulmonary arterial hypertension
- NCT number
- NCT01065454
- EU CT number
- 2023-507001-34-00
- EudraCT number
- 2009-015878-35
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Types of pulmonary hypertension other than group 2.1 of Dana Point Classification
Who the study is looking for
- Male and female patients with symptomatic pulmonary hypertension due to left ventricular systolic dysfunction despite optimized heart failure therapy
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (78)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - | Innsbruck | Austria | Unknown status |
| - | Vienna | Austria | Unknown status |
| - | Herston | Australia | Unknown status |
| - | Melbourne | Australia | Unknown status |
| - | Sydney | Australia | Unknown status |
| - | Aalst | Belgium | Unknown status |
| - | Brussels | Belgium | Unknown status |
| - | Ghent | Belgium | Unknown status |
| - | Leuven | Belgium | Unknown status |
| - | Edmonton | Canada | Unknown status |
| - | Montreal | Canada | Unknown status |
| - | Québec | Canada | Unknown status |
| - | Vancouver | Canada | Unknown status |
| - | Geneva | Switzerland | Unknown status |
| - | Lugano | Switzerland | Unknown status |
| - | Zurich | Switzerland | Unknown status |
| - | Beijing | China | Unknown status |
| - | Shanghai | China | Unknown status |
| - | Brno | Czechia | Unknown status |
| - | Olomouc | Czechia | Unknown status |
| - | Prague | Czechia | Unknown status |
| - | Augsburg | Germany | Unknown status |
| - | Cologne | Germany | Unknown status |
| - | Erfurt | Germany | Unknown status |
| - | Greifswald | Germany | Unknown status |
| - | Heidelberg | Germany | Unknown status |
| - | Aarhus N | Denmark | Unknown status |
| - | A Coruña | Spain | Unknown status |
| - | Barcelona | Spain | Unknown status |
| - | Madrid | Spain | Unknown status |
| - | Majadahonda | Spain | Unknown status |
| - | Murcia | Spain | Unknown status |
| - | Palma | Spain | Unknown status |
| - | Valencia | Spain | Unknown status |
| - | Bron | France | Unknown status |
| - | Lille | France | Unknown status |
| - | Nantes | France | Unknown status |
| - | Pessac | France | Unknown status |
| - | Rouen | France | Unknown status |
| - | Toulouse | France | Unknown status |
| - | Cambridge | United Kingdom | Unknown status |
| - | London | United Kingdom | Unknown status |
| - | Naples | Italy | Unknown status |
| - | Pavia | Italy | Unknown status |
| - | Arakawa-ku | Japan | Unknown status |
| - | Higashiibaraki | Japan | Unknown status |
| - | Kita-ku, Osaka | Japan | Unknown status |
| - | Kusatsu | Japan | Unknown status |
| - | Nagoya | Japan | Unknown status |
| - | Ōgaki | Japan | Unknown status |
| - | Osaka | Japan | Unknown status |
| - | Sendai | Japan | Unknown status |
| - | Seto | Japan | Unknown status |
| - | Shinjuku-Ku | Japan | Unknown status |
| - | Suita | Japan | Unknown status |
| - | Sunto | Japan | Unknown status |
| - | Tanabe | Japan | Unknown status |
| - | Tsu | Japan | Unknown status |
| - | Amsterdam | Netherlands | Unknown status |
| - | Nijmegen | Netherlands | Unknown status |
| - | Bydgoszcz | Poland | Unknown status |
| - | Gdansk | Poland | Unknown status |
| - | Warsaw | Poland | Unknown status |
| - | Singapore | Singapore | Unknown status |
| - | Baltimore | United States | Unknown status |
| - | Boston | United States | Unknown status |
| - | Cincinnati | United States | Unknown status |
| - | Fairfield | United States | Unknown status |
| - | Falls Church | United States | Unknown status |
| - | Iowa City | United States | Unknown status |
| - | Los Angeles | United States | Unknown status |
| - | Miami | United States | Unknown status |
| - | Milwaukee | United States | Unknown status |
| - | Rochester | United States | Unknown status |
| - | San Diego | United States | Unknown status |
| - | St Louis | United States | Unknown status |
| - | Torrance | United States | Unknown status |
| - | Westminster | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.